Printer Friendly

NEW BIOTECHNOLOGY LAW FIRM TO OPEN

 NEW BIOTECHNOLOGY LAW FIRM TO OPEN
 SAN DIEGO, Calif., April 30 /PRNewswire/ -- A new law firm


specializing exclusively in biotechnology intellectual property law will commence practice on May 1, 1992. Cathryn Campbell, formerly a shareholder with Pretty, Schroeder, Brueggemann & Clark and Mauricio Flores, formerly a partner at Pillsbury, Madison & Sutro, are joining to form Campbell and Flores. The new firm will include eight attorneys and scientific consultants from their previous firms.
 All of the attorneys in Campbell and Flores have worked extensively with the biotechnology industry. The former Pretty, Schroeder, Brueggmann & Clark attorneys specialize in patent matters, particularly processing patent prosecution for highly complex and technical inventions. Those from Pillsbury, Madison & Sutro bring experience in complex high technology litigation, licensing, corporate collaboration, technology transfer and proprietary strategy.
 "It has become increasingly apparent to me over the years that the various legal issues confronting the biotechnology industry cannot be considered in a vacuum. Because of the close interrelation between obtaining and exploiting patent protection, we believe our clients are best served by a group with broad legal experience, who specialize only in biotechnology issues," says Campbell, who holds a Ph.D. in genetics.
 In addition to Campbell and Flores, the new firm will include Theresa A. Brown, Toni Amicarella, Lynn M. Brennan, Marnie W. Barnhorst, Deborah A. Dugan and Richard J. Imbra. The firm will occupy the former San Diego offices of Pretty, Schroeder, Brueggemann & Clark, located at 4370 La Jolla Village Dr., Suite 700, San Diego, CA 92122.
 Among the clients of the new firm are Telios Pharmaceuticals Inc., La Jolla Cancer Research Foundation, Molecular Biosystems Inc., IXSYS Inc., The Immune Response Corp. and the University of California. "Many of these clients have been with me for the last eight years," says Campbell.
 Campbell and Flores represents Molecular Biosystems Inc., and Syngene Inc. in a patent infringement action pending in the Southern District of California. Flores represented IXSYS Inc. in a complex suite against Stratagene Inc.
 "Biotech intellectual property litigation demands specialized knowledge of the technology and patent law, as well as experience in complex litigation and the management of large litigation teams. We will be able to offer our clients all of those skills in a small, focused litigation team," says Flores.
 -0- 4/30/92
 /CONTACT: Theresa A. Brown, 619-535-9001, for Campbell and Flores/ CO: Campbell and Flores ST: California IN: MTC SU:


AL-CH -- SD004 -- 4995 04/30/92 13:30 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 30, 1992
Words:404
Previous Article:SPRINT PROVIDES HANDY LONG DISTANCE INFORMATION IN COMPACT SIZE
Next Article:VIRGINIA BEACH FEDERAL FINANCIAL CORPORATION ANNOUNCES ANNUAL MEETING OF STOCKHOLDERS AND REGULAR QUARTERLY DIVIDEND


Related Articles
Seeds of change: the implications of biotechnology patents.
Biotechnology Council of New Jersey Announces First Technology Tax Benefit Transfer Takes Place.
Buchanan Ingersoll Lands Former Brobeck Attorneys on Both Coasts: Firm Boosts IP in San Diego and Banking in New York.
Winstead Launches Biotechnology Practice; Law Firm Adds Extensive Biotech and Pharmaceutical Related Legal Expertise to Assist and Advise Clients in...
Miller Canfield Opens Office in Cambridge, Mass.; Expands Biotechnology, IP and Life Sciences Practice.
Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters